Learn more about whether KKR & Co. Inc. or UBS Group AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

HSBC analyst Vikram Gandhi downgraded KKR (KKR) to Hold from Buy with a price target of $173, up from $153. While the firm views KKR as a ...

In the assessment of 12-month price targets, analysts unveil insights for KKR, presenting an average target of $169.0, a high estimate of $185.00, and a low estimate of $151.00. This current average ...

Henry Schein Inc., a leading healthcare solutions provider, has secured a $250 million investment from private equity ...

KKR is set to become the largest non-index fund shareholder in Henry Schein, acquiring a 12% stake through a $250 million investment.

Gunjan Kedia is set to take the helm of the nation's largest regional bank in mid-April, becoming its first woman CEO. Wells Fargo said that its 2022 consent order with the Consumer Financial ...

Henry Schein has received a strategic investment of $250 million from KRR, giving the global investment firm a 12% stake in the company, with the option to purchase additional shares ...

Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...

Finally, we have a deal from KKR which has made an investment in healthcare and dental care provider Henry Schein.

Henry Schein shares up on strategic investment from KKR, management appointments, share buyback, and preliminary results.

The private-equity firm KKR has taken a big stake in the medical- and dental-supply company Henry Schein and plans to work ...